Saturday, June 13, 2020 7:11:30 PM
Here is a general synopsis of what is going on:
CEO Dr David Dalton:
Former Rite Aid VP of operations.
First black big pharmacy executive in the US.
In Four Halls of Fame.
Senatorial Medal of Freedom and Veteran.
Founded Managed Care Rx, merged it with Bergen Brunswick, a drug wholesale company - sales in excess of 14 billion.
Executive Chairman of Wellness TeleMed(Telemedicine) and WellnessRx (Mental Health and Substance abuse clinics)
BOD: So far we know John C Peoples former Merck VP for Western Markets and Ken Grant former Johns Hopkins VP
Subsidiaries rolling into the Conglomerate as stated publicly by Dr Dalton:
Wellness Teladoc which has a big connection to TDOC
Wellness RX Medicaid in 26 states and Gold Standard for pharmacists
Time Organization CARF accredited Clinics to fight the opioid crisis
HRI Health Resources Inc PBM (Pharmacy benefits management) $204 Million revs last year (Docs private company for many years rolling up with the other private companies as he has alluded to)
PPSI (always been a UNVC sub) Provides starter scripts to Doctors
Euromed Our Israeli medical cannabis company that has a grow license in Israel thru their subsidiary Eurocann Agritech. 30+ CBD meds for sale in Israel, the EU and US
There are numerous other companies that we are known to have partnerships with.
Dr Dalton has communicated to shareholders that the last thing we are waiting for is Medicare Certification. Application was made weeks ago and the only change requested by Medicare was a change in the way the company name was listed on the forms.
That's it.
That change has been submitted and approval will be granted any day now.
Please follow @DrDavidDalton1 on Twitter:
https://mobile.twitter.com/DrDavidDalton1/with_replies
And on Linkedin:
https://www.linkedin.com/in/david-dalton-58008952/
“When the debate is lost, slander becomes the tool of the loser." - Socrates
"A lie can travel half way around the world while the truth is putting on its shoes." - Charles Spurgeon
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM